NCT00040495已完成3 期
An Efficacy and Safety Study of Intravenous Pantoprazole in the Prevention of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 149 人开始时间: 2001年4月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 149
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.
研究设计
- 研究类型
- Interventional
- 主要目的
- Prevention
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must be men or non-pregnant women at least 18 years of age
- •Patients who present with a gastric or duodenal ulcer
排除标准
- •Patients with ulcer appearance of clean base (non-oozing, non-spurting) or flat pigmented spot; adherent clots not removed by irrigation
- •Patients presenting with active bleeding and/or NBVV at 2 or more separate sites
- •Patients with any severe concomitant diseases, eg, end stage liver or renal disease, or unstable cardiovascular, pulmonary, renal, hepatic, or gastrointestinal diseases
研究者
相似试验
Unknown
不适用
Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer BleedingBleeding Gastric UlcerBleeding Duodenal UlcerNCT02108756Chia Tai Tianqing Pharmaceutical Group Co., Ltd.272
已完成
4 期
Intravenous (IV) Pantoprazole in Erosive EsophagitisEsophagitisNCT00133770Emory University20
Unknown
4 期
The Efficacy of Pantoprazole Treatment in Patients With Functional DyspepsiaNonulcer DyspepsiaNCT01608750Bezmialem Vakif University200
Unknown
2 期
A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer CellsGastric Cancer With Positive Exfoliative Cancer CellsNCT03718624Hebei Medical University36
撤回
4 期
Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer RebleedingPeptic UlcerNCT00881413Lotung Poh-Ai Hospital